Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iannis Aifantis

Showing results (141-150 of 206) with videos related to

Pageof 21
Sort By:
Cancer Discovery|April 24, 2023
Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid LeukemiaChristina Glytsou, Xufeng Chen, Emmanouil Zacharioudakis, et al.
Cancer Cell|January 15, 2020
Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and MetastasisDouglas Hanniford, Alejandro Ulloa-Morales, Alcida Karz, et al.
Research Square|February 23, 2026
Type-2-immune history imprints local training in nerve-airway associated interstitial macrophages (NAMs) for disease tolerance during respiratory viral infectionPayal Damani-Yokota, Yavor Yordanov, Eduardo D Bernier, et al.
Nature Genetics|March 24, 2020
Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemiaAndreas Kloetgen, Palaniraja Thandapani, Panagiotis Ntziachristos, et al.
Nature Immunology|August 14, 2019
The E3 ubiquitin ligase SPOP controls resolution of systemic inflammation by triggering MYD88 degradationMaria Guillamot, Dahmane Ouazia, Igor Dolgalev, et al.
Cancer Cell|September 14, 2010
The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemiaLluis Espinosa, Severine Cathelin, Teresa D'Altri, et al.
Leukemia|November 28, 2019
Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALLSonia Rodriguez, Christina Abundis, Francesco Boccalatte, et al.
Pharmacology & Therapeutics|August 3, 2019
Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule miningKonstantinos Vougas, Theodore Sakellaropoulos, Athanassios Kotsinas, et al.
Nature Immunology|September 22, 2022
NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemiaMatthew T Witkowski, Soobeom Lee, Eric Wang, et al.
Nature Communications|April 14, 2023
Oncogenic drivers dictate immune control of acute myeloid leukemiaRebecca J Austin, Jasmin Straube, Rohit Halder, et al.
Pageof 21

Showing results (141-150 of 206) with videos related to

Sort By:
Pageof 21
Cancer Discovery|April 24, 2023
Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid LeukemiaChristina Glytsou, Xufeng Chen, Emmanouil Zacharioudakis, et al.
Cancer Cell|January 15, 2020
Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and MetastasisDouglas Hanniford, Alejandro Ulloa-Morales, Alcida Karz, et al.
Research Square|February 23, 2026
Type-2-immune history imprints local training in nerve-airway associated interstitial macrophages (NAMs) for disease tolerance during respiratory viral infectionPayal Damani-Yokota, Yavor Yordanov, Eduardo D Bernier, et al.
Nature Genetics|March 24, 2020
Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemiaAndreas Kloetgen, Palaniraja Thandapani, Panagiotis Ntziachristos, et al.
Nature Immunology|August 14, 2019
The E3 ubiquitin ligase SPOP controls resolution of systemic inflammation by triggering MYD88 degradationMaria Guillamot, Dahmane Ouazia, Igor Dolgalev, et al.
Cancer Cell|September 14, 2010
The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemiaLluis Espinosa, Severine Cathelin, Teresa D'Altri, et al.
Leukemia|November 28, 2019
Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALLSonia Rodriguez, Christina Abundis, Francesco Boccalatte, et al.
Pharmacology & Therapeutics|August 3, 2019
Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule miningKonstantinos Vougas, Theodore Sakellaropoulos, Athanassios Kotsinas, et al.
Nature Immunology|September 22, 2022
NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemiaMatthew T Witkowski, Soobeom Lee, Eric Wang, et al.
Nature Communications|April 14, 2023
Oncogenic drivers dictate immune control of acute myeloid leukemiaRebecca J Austin, Jasmin Straube, Rohit Halder, et al.
Pageof 21